As per the news reports, Alkem is now exploring a potential buyout of J B Chemicals & Pharmaceuticals (JB). Torrent that was the speculated front runner for JB has paused talks due to the valuation differences. EQT, a Swedish investment major has also been said to give the acquisition a pass due to the valuation … Read more
Mankind Pharma (MPL) is acquiring 100% of Bharat Serums (BSV) from the private equity major, Advent. BSV has a niche portfolio offering in Women’s Health, encompassing the entire lifecycle – from fertility to post-pregnancy. Deal is agreed at an Enterprise Valuation (EV) of Rs 13,630 cr translating to 28x of FY24 EBITDA. For comparison MPL’s … Read more
The discovery of an innovative drug represents a significant breakthrough in the field of anti-aging research. The newly discovered drug aims to inhibit a protein associated with aging, perhaps prolonging life and enhancing general health. Rats included in the experiments had a notable 25% longer lifespan and several other health benefits from the medication. The … Read more
The Company has entered into a definitive agreement with British Consumer Healthcare player Haleon plc and its associate companies (Haleon) to acquire their consumer healthcare brands in the Nicotine Replacement Therapy (NRT) category, outside the United States. The acquisition has been done through Dr. Reddy’s Laboratories SA, Switzerland, a wholly owned subsidiary of the Company. … Read more
Private equity major, Advent in December 2022 had taken a majority control in Suven Pharmaceuticals (SP). At that time, Advent had disclosed in the filings that it intends to explore the merger of it’s umbrella CDMO entity, Cohance Lifesciences into SP and hence create an integrated, larger and listed franchise with the associated benefits. Now, … Read more